Newark-based New Jersey Innovation Institute (NJII), a New Jersey Institute of Technology Corporation, signs an industry participation agreement with Pall Corporation to support the development of its BioPharmaceutical Innovation iLab. The partnership will support two key Centers at NJII that will advance the manufacturing of new cell and gene therapies: the Cell and Gene Therapy Development Center and the Center of Advanced Biologic Manufacturing. Read more here.